Case report: a rare case of diffusely metastatic BRAF V600E-mutated colorectal cancer with concomitant infiltration of the skin and parotid gland
Metastastic disease affects up to 50% of colorectal cancer (CRC) patients and is associated with particularly poor outcomes in the presence of the BRAF V600E mutation. Herein, we report a patient with initial diagnosis of stage IIIc CRC, who presented during follow-up (adjuvant phase) with dysphagia...
Saved in:
Main Authors: | Aristeidis E. Boukouris, Ioannis Kokkinakis, Elias Drakos, Maria Sfakianaki, Maria Tzardi, Dimitrios Mavroudis, John Souglakos |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1512000/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Frecuencia de la inmunosupresión de BRAF V600E en ameloblastomas: Un análisis multi-insituticional de 86 casos en América Latina
by: Lauren Frenzel Schuch, et al.
Published: (2024-12-01) -
RATIONAL DRUG DESIGN OF POTENT V600E-BRAF KINASE INHIBITORS THROUGH MOLECULAR DOCKING SIMULATION
by: Bello Abdullahi Umar, et al.
Published: (2019-12-01) -
BRAF V600E-mutated lung adenocarcinoma with thyroid metastasis as the initial manifestation: a case report
by: Yufei Liu, et al.
Published: (2025-02-01) -
BRAF inhibitor monotherapy in BRAFV600E-mutated pediatric low-grade glioma: a single center’s experience
by: S. S. McThenia, et al.
Published: (2025-01-01) -
A Case Presentation of a Patient with Microsatellite Instability and BRAF Mutant Metastatic Colon Cancer and Bibliography Update
by: K. Thomopoulou, et al.
Published: (2019-01-01)